Previous 10 | Next 10 |
Q2 Revenue Expected to be in the range of $0.6 million to $0.7 million Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders an...
Myomo ( MYO +4.3% ) said that for patient convenience it has successfully completed its initiative to conduct safe patient screenings remotely using telehealth technologies . More news on: Myomo, Inc., Healthcare stocks news, Read more ...
Edesa Biotech (NASDAQ: EDSA ) +218% on launch of COVID-19 study in Canada. More news on: Edesa Biotech, Inc., Brickell Biotech, Inc., BioHiTech Global, Inc., Stocks on the move, , Read more ...
Increased Convenience for Patient Candidates; Increased Productivity and Reduced Costs for Company Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering fr...
Myomo, Inc. (MYO) Q1 2020 Results Conference Call May 14, 2020 04:30 PM ET Company Participants Kim Golodetz - Investor Relations-LHA Paul Gudonis - Chief Executive Officer Dave Henry - Chief Financial Officer Conference Call Participants Scott Henry - ROTH Capital Greg B...
Myomo (NYSEMKT: MYO ): Q1 GAAP EPS of -$2.51 misses by $0.45 . More news on: Myomo, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
21% Year-Over-Year Revenue Growth; 51% Sequential Increase in Authorization Backlog Conference call begins at 4:30 p.m. Eastern time today Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers inc...
Management to host Financial Results Conference Call at 4:30 p.m. ET Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and up...
Gainers: Medigus (NASDAQ: MDGS ) +44% . More news on: Medigus Ltd., Indonesia Energy Corporation Limited, National Holdings Corporation, Stocks on the move, , Read more ...
Medigus (NASDAQ: MDGS ) +76% on first order for COVID-19 blood test . More news on: Medigus Ltd., Myomo, Inc., Akari Therapeutics, Plc, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-10 17:00:05 ET Scott Henry from Industrial Alliance Securities issued a price target of $5.75 for MYO on 2024-07-10 15:33:00. The adjusted price target was set to $5.75. At the time of the announcement, MYO was trading at $4.97. The overall price target consensus...
2024-07-10 16:15:02 ET Alliance Global Partners analyst issues BUY recommendation for MYO on July 10, 2024 03:33PM ET. The previous analyst recommendation was Buy. MYO was trading at $4.97 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
2024-07-09 10:30:11 ET Lake Street analyst issues BUY recommendation for MYO on July 9, 2024 08:45AM ET. The previous analyst recommendation was Buy. MYO was trading at $4.07 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst...